LEMAITRE VASCULAR INC's ticker is LMAT and the CUSIP is 525558201. A total of 168 filers reported holding LEMAITRE VASCULAR INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $61,364 | +10.1% | 1,192 | -1.6% | 0.00% | 0.0% |
Q4 2022 | $55,710 | -24.7% | 1,211 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $74,000 | +48.0% | 1,211 | -4.0% | 0.00% | 0.0% |
Q4 2020 | $50,000 | +6.4% | 1,261 | -11.1% | 0.00% | 0.0% |
Q3 2020 | $47,000 | +161.1% | 1,418 | +91.6% | 0.00% | +100.0% |
Q1 2020 | $18,000 | -18.2% | 740 | +16.9% | 0.00% | 0.0% |
Q4 2019 | $22,000 | +29.4% | 633 | +4.5% | 0.00% | 0.0% |
Q3 2019 | $17,000 | 0.0% | 606 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $17,000 | -70.2% | 606 | -66.9% | 0.00% | -75.0% |
Q1 2019 | $57,000 | +32.6% | 1,830 | +1.7% | 0.00% | 0.0% |
Q4 2018 | $43,000 | -45.6% | 1,800 | -12.2% | 0.00% | -33.3% |
Q3 2018 | $79,000 | +11.3% | 2,050 | +7.9% | 0.01% | +20.0% |
Q2 2018 | $71,000 | -20.2% | 1,900 | -22.4% | 0.01% | -28.6% |
Q1 2018 | $89,000 | +6.0% | 2,450 | -7.5% | 0.01% | 0.0% |
Q4 2017 | $84,000 | -23.6% | 2,650 | -10.2% | 0.01% | -46.2% |
Q3 2017 | $110,000 | – | 2,950 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWM Investment Company, Inc. | 350,194 | $11,724,000 | 1.96% |
Ranger Investment Management | 699,843 | $23,431,000 | 1.64% |
THB ASSET MANAGEMENT | 392,100 | $13,127,000 | 1.60% |
PERKINS CAPITAL MANAGEMENT INC | 64,550 | $2,161,000 | 1.55% |
Conestoga Capital Advisors, LLC | 1,392,591 | $46,624,000 | 1.50% |
Summit Creek Advisors LLC | 213,761 | $7,157,000 | 1.28% |
Biondo Investment Advisors, LLC | 107,405 | $3,603,000 | 0.91% |
Concorde Asset Management, LLC | 21,207 | $710,000 | 0.81% |
Capital Impact Advisors, LLC | 51,542 | $1,739,000 | 0.64% |
Sapphire Star Partners LP | 12,290 | $412,000 | 0.42% |